ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 025,97
0,41%
Dow Jones
38 708,68
0,06%
DAX
18 667,82
1,00%
Brent Oil
80,32
-0,60%
Bitcoin
69 814,99
3,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Celularity Inc (CELUW)

  7. Celularity Inc (CELUW) Actualités

CELUW

Celularity (CELUW)

Celularity Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CELUW
DateHeureSourceTitreSymboleSociété
03/06/202414h38GlobeNewswire Inc.Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CELUWCelularity Inc
24/05/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUWCelularity Inc
24/05/202423h15GlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q FilingNASDAQ:CELUWCelularity Inc
15/05/202423h15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CELUWCelularity Inc
14/05/202415h15GlobeNewswire Inc.Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T TherapyNASDAQ:CELUWCelularity Inc
22/04/202414h00GlobeNewswire Inc.Celularity Inc. to Host Investor and Analyst Research & Development DayNASDAQ:CELUWCelularity Inc
19/04/202423h30GlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingNASDAQ:CELUWCelularity Inc
18/04/202422h30GlobeNewswire Inc.Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024NASDAQ:CELUWCelularity Inc
15/04/202414h00GlobeNewswire Inc.Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial ProductsNASDAQ:CELUWCelularity Inc
08/04/202415h00GlobeNewswire Inc.Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental CellsNASDAQ:CELUWCelularity Inc
26/03/202414h00GlobeNewswire Inc.Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3LNASDAQ:CELUWCelularity Inc
20/03/202414h15GlobeNewswire Inc.Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular DystrophyNASDAQ:CELUWCelularity Inc
14/03/202414h15GlobeNewswire Inc.Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE SummitNASDAQ:CELUWCelularity Inc
12/03/202414h20GlobeNewswire Inc.Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World CongressNASDAQ:CELUWCelularity Inc
07/03/202415h35GlobeNewswire Inc.Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental CellsNASDAQ:CELUWCelularity Inc
23/02/202422h10GlobeNewswire Inc.Celularity Announces 1-for-10 Reverse Stock SplitNASDAQ:CELUWCelularity Inc
 Showing the most relevant articles for your search:NASDAQ:CELUW

Dernières Valeurs Consultées

BOV
T1OW34M
American Tower
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés